Rejuran I - Eye Treatment (Made in Korea)

・Improves skin firmness and elasticity
・Reduces fine lines
・High moisturizing effect
・Minimizes pores
・Improves skin texture
・Promotes skin regeneration

After your consultation with the doctor, the solution will be injected into the treatment area.The treatment takes approximately 20 to 30 minutes.(If you desire topical anesthetic cream, please allow an additional 15 minutes.)We recommend 3 to 4 treatment sessions, once every 2 to 4 weeks.

The following payment methods are accepted at our clinic:

・Cash
・Credit card
・E-money
・QR code payment

We accept both advance payments and same-day payments.

・Redness and swelling at the injection site
・Bruising
・Pain and warmth
・Mild swelling

These usually improve within a few days to a week.

・On the day of the treatment, please refrain from strenuous exercise, alcohol consumption, and prolonged bathing.
・Avoid strong stimulation or massage to the treated area for several days.
・Take measures to protect yourself from UV radiation.

・Those who are pregnant or breastfeeding
・Those with infections or inflammation in the treatment area
・Those allergic to fish (salmon)-derived ingredients
・Those allergic to lidocaine
・Those whom a doctor deems unsuitable for treatment

This product is not available for delivery. Please visit our clinic on your reserved date, and the treatment will be performed after a medical examination and consultation with a doctor.

〈Clarification that the product is an unapproved drug, etc.〉Rejuran HB Plus used at our clinic is an unapproved medical device that has not been approved under Japan's Pharmaceuticals and Medical Devices Act.〈Clarification of acquisition channels, etc.〉It is legally imported from a South Korean manufacturer under the responsibility of a physician.〈Availability of approved drugs, etc. in Japan〉There are no domestically approved medical devices with the same ingredients or performance.〈Safety, etc. in other countries〉It is widely used in aesthetic medicine, primarily in South Korea.〈About the Pharmaceutical Adverse Event Relief System〉As it is an unapproved medical device, it is not covered by Japan's Pharmaceutical Adverse Event Relief System.